---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-135399"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T04:49:42.439490+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# PSTV raises $7.25M via private placement of shares and warrants

## Summary
- Gross proceeds of $7.25M from private placement of 3,591,532 units at $2.022/$2.158 per unit.
- Units consist of one share (or pre-funded warrant) plus Series A and Series B warrants.
- Series A warrants exercisable for 5 years, Series B warrants exercisable for 1 year after registration effectiveness.
- Potential additional proceeds up to $12M from warrant exercises.
- Insiders purchased $98,500 of securities.

## SEC filing metadata
- accession: 0001193125-24-135399
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312524135399/0001193125-24-135399-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312524135399/d827838d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-135399
- JSON: https://secwatch.observer/filing/0001193125-24-135399.json
- Plain text: https://secwatch.observer/filing/0001193125-24-135399.txt

## Key facts
- Material Agreements
  PLUS THERAPEUTICS, INC. entered into Securities Purchase Agreement with certain investors identified on the signature page thereto (collectively, the "Purchasers") valued at approximately $6.5 million (effective 2024-05-05).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain investors identified on the signature page thereto (collectively, the "Purchasers")
  - Value: approximately $6.5 million
  - Effective: 2024-05-05
  source text: On May 5, 2024, Plus Therapeutics, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors identified on the signature page thereto (collectively, the “Purchasers”) for a private placement of securities (the “Initial Subscription”) for gross proceeds at the Closing Date (as defined below) of approximately $6.5 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312524135399/0001193125-24-135399-index.htm
- Material Agreements
  PLUS THERAPEUTICS, INC. amended Securities Purchase Agreement with certain investors identified on the signature page thereto (collectively, the "Purchasers") valued at approximately $0.75 million (effective 2024-05-08).
  - Action: amendment
  - Agreement: equity purchase
  - Counterparty: certain investors identified on the signature page thereto (collectively, the "Purchasers")
  - Value: approximately $0.75 million
  - Effective: 2024-05-08
  source text: On May 8, 2024, the Company entered into an amendment to the Securities Purchase Agreement (the “Amendment”) that increased the aggregate subscription amount by approximately $0.75 million (the “Additional Subscription”) for aggregate initial gross proceeds of approximately $7.25 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312524135399/0001193125-24-135399-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.